The Impact of Systemic Drug Therapies (Bisphosphonates and Immunosuppressants) on Dental Implant Success: A clinical review

The Impact of Systemic Drug Therapies on Dental Implant Success

Authors

  • Khalid Eisa Aldabeab King Fahd Military Medical Complex, Dhahran Saudi Arabia
  • Asim Alsuwaiyan King Fahd Military Medical Complex, Dhahran Saudi Arabia

DOI:

https://doi.org/10.31661/gmj.v13iSP1.3666

Keywords:

Dental Implants; Bisphosphonates; Immunosuppressants; Osteonecrosis of the Jaw; Osseointegration; Implant Success

Abstract

Under normal physiological conditions, dental implants are a reliable and effective choice for tooth replacement with high success rates. However, compromised implant success is more closely related to systemic drug therapies like bisphosphonates and immunosuppressants used in patients.
This review aims to identify key patterns of implant success and complications among patients undergoing long-term systemic drug therapy and provide clinical recommendations for optimizing outcomes. Bisphosphonates, especially in their intravenous (IV) forms, inhibit osteoclast activity and decrease bone turnover, which may negatively impact osseointegration and increase the incidence of osteonecrosis of the jaw (ONJ). Immunosuppressants are commonly associated with delayed wound healing and a higher risk of infection, complicating implant osseointegration due to their effect on the immune response. Clinicians must adopt personalized approaches to prevent complications in this patient population. Moreover, future studies should aim to explore the long-term effects of systemic drug therapies, particularly regarding dosages, treatment durations, combinations, and newer medications, while investigating drug interactions and dose-response relationships to provide more specific guidelines for clinicians on implant outcomes.

References

Get persistent links for your reference list or bibliography.

Copy and paste the list, we’ll match with our metadata and return the links.

Members may also deposit reference lists here too.

Bornstein MM, Schmid B, Belser UC, Lussi A, Buser D. Conditions, treatments, and risks of therapy in implant dentistry: a review. Quintessence Int. 2009;40(9):743-53.

Javed F, Almas K. Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review. J Periodontol. 2010;81(4):479-84.

https://doi.org/10.1902/jop.2009.090587

PMid:20367090

Al-Noaman AS. Influence of Oral Bisphosphonate on Dental Implant: A Review. Med J Babylon. 2022 Apr;19(2):180-4.

https://doi.org/10.4103/MJBL.MJBL_96_21

Chadha R, Jalali E, Anwar T. Osseointegration of implants in patients with osteonecrosis of the jaw: A case report. J Maxillofac Oral Surg. 2013;12(3):290-3.

Radzewski R, Osmola K. Osseointegration of Dental Implants in Organ Transplant Patients Undergoing Chronic Immunosuppressive Therapy. Implant Dent. 2019 Oct;28(5):447-54.

https://doi.org/10.1097/ID.0000000000000916

PMid:31306295

Ata-Ali J, Ata-Ali F, Peñarrocha-Oltra D, Galindo-Moreno P. What is the impact of bisphosphonate therapy upon dental implant survival A systematic review and meta-analysis. Clin Oral Implants Res. 2016 Feb;27(2):e38-46.

https://doi.org/10.1111/clr.12526

PMid:25406770

Kafantaris NM. The Impact of Bisphosphonate Therapy Upon Oral Implant Treatment; A Systematic Review. Adv Dent Oral Health. 2016 Dec 14;3(2):555610.

https://doi.org/10.19080/ADOH.2016.03.555610

Famili P, Quigley S, Mosher T. Survival of dental implants among post-menopausal female dental school patients taking oral bisphosphonates: a retrospective study. Compend Contin Educ Dent Jamesburg NJ 1995. 2011;32(6):E106-109.

Shabestari GO, Shayesteh YS, Khojasteh A, Alikhasi M, Moslemi N, Aminian A, et al. Implant Placement in Patients with Oral Bisphosphonate Therapy: A Case Series. Clin Implant Dent Relat Res. 2010 Sep;12(3):175-80.

https://doi.org/10.1111/j.1708-8208.2009.00150.x

PMid:19438964

Kim I, Ki H, Lee W, Kim H, Park J. The effect of systemically administered bisphosphonates on bony healing after tooth extraction and osseointegration of dental implants in a rabbit model. Int J Oral Maxillofac Implants. 2013;28(5):1194-200.

https://doi.org/10.11607/jomi.2685

PMid:24066308

Tsetsenekou E, Papadopoulos T, Kalyvas D, Papaioannou N, Tangl S, Watzek G. The influence of alendronate on osseointegration of nanotreated dental implants in New Zealand rabbits. Clin Oral Implants Res. 2012 Jun;23(6):659-66.

https://doi.org/10.1111/j.1600-0501.2011.02189.x

PMid:21488972

Korn P, Kramer I, Schlottig F, Tödtmann N, Eckelt U, Bürki A, et al. Systemic sclerostin antibody treatment increases osseointegration and biomechanical competence of zoledronic-acid-coated dental implants in a rat osteoporosis model. Eur Cell Mater. 2019 May 21;37:333-46.

https://doi.org/10.22203/eCM.v037a20

PMid:31112281

Inoue M, Matsumoto C, Nakajima K, Kuroshima S, Sawase T. Alendronate/dexamethasone combination therapy worsens soft and hard tissue wound healing around implants in rat maxillae. Bone. 2021 Jul;148:115942.

https://doi.org/10.1016/j.bone.2021.115942

PMid:33836307

Sculean A, Gruber R, Bosshardt DD. Soft tissue wound healing around teeth and dental implants. J Clin Periodontol [Internet]. 2014 Apr [cited 2024 Oct 15];41(s15):12206.

https://doi.org/10.1111/jcpe.12206

Yamazaki T, Yamori M, Ishizaki T, Asai K, Goto K, Takahashi K. Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: A cohort study. Int J Oral Maxillofac Surg. 2012;41(11):1397-403.

https://doi.org/10.1016/j.ijom.2012.06.020

PMid:22840716

Rai S, Rai A, Kumar T, Kumari M, Somanna M, Bandgar S. Immediately loaded single unit dental implants: A clinical study. J Pharm Bioallied Sci. 2020;12(5):245.

https://doi.org/10.4103/jpbs.JPBS_72_20

PMid:33149465 PMCid:PMC7595488

Thomas JG, Ouanounou A. Medication-related osteonecrosis of the jaw: a narrative review of risk factors, diagnosis, and management. Front Oral Maxillofac Med [Internet]. 2023 Dec 30 [cited 2024 Oct 15];5:106.

https://doi.org/10.21037/fomm-21-106

Liddelow G, Klineberg I. Patient-related risk factors for implant therapy A critique of pertinent literature. Aust Dent J. 2011;56(4):417-26.

https://doi.org/10.1111/j.1834-7819.2011.01367.x

PMid:22126353

Wang H, Weber D, McCauley LK. Effect of Long-Term Oral Bisphosphonates on Implant Wound Healing: Literature Review and a Case Report. J Periodontol. 2007 Mar;78(3):584-94.

https://doi.org/10.1902/jop.2007.060239

PMid:17335384

Wilkinson JM, Little DG. Bisphosphonates in orthopedic applications. Bone. 2011 Jul;49(1):95-102.

https://doi.org/10.1016/j.bone.2011.01.009

PMid:21256254

Scully C, Madrid C, Bagan J. Dental Endosseous Implants in Patients on Bisphosphonate Therapy. Implant Dent. 2006 Sep;15(3):212-8.

https://doi.org/10.1097/01.id.0000236120.22719.02

PMid:16966893

Hokugo A, Kanayama K, Sun S, Morinaga K, Sun Y, Wu Q, et al. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice. Bone. 2019 Jun;123:115-28.

https://doi.org/10.1016/j.bone.2019.03.027

PMid:30926440 PMCid:PMC7282713

Holzinger D, Seemann R, Matoni N, Ewers R, Millesi W, Wutzl A. Effect of Dental Implants on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg. 2014 Oct;72(10):1937.e1-1937.e8.

https://doi.org/10.1016/j.joms.2014.04.037

PMid:25234534

de-Freitas NR, Lima LB, de-Moura MB, Veloso-Guedes C do CF, Simamoto-Júnior PC, de-Magalhães D. Bisphosphonate treatment and dental implants: A systematic review. Med Oral Patol Oral Cir Bucal. 2016 Sep;21(5):e644-51.

https://doi.org/10.4317/medoral.20920

PMid:27475681 PMCid:PMC5005105

Sulaiman N, Fadhul F, Chrcanovic BR. Bisphosphonates and dental implants: A systematic review and meta-analysis. Materials. 2023;16(18):6078.

https://doi.org/10.3390/ma16186078

PMid:37763356 PMCid:PMC10532755

Burtscher D, Torre DD. Dental implant procedures in immunosuppressed organ transplant patients: a systematic review. Int J Oral Maxillofac Surg. 2022 Mar 1;51(3):380-7.

https://doi.org/10.1016/j.ijom.2021.06.008

PMid:34274207

Fireman M, DiMartini AF, Armstrong SC, Cozza KL. Immunosuppressants. Psychosomatics. 2004 Jul;45(4):354-60.

https://doi.org/10.1176/appi.psy.45.4.354

PMid:15232051

Hayashi M, Morimoto Y, Iida T, Tanaka Y, Sugiyama S. Risk of Delayed Healing of Tooth Extraction Wounds and Osteonecrosis of the Jaw among Patients Treated with Potential Immunosuppressive Drugs: A Retrospective Cohort Study. Tohoku J Exp Med. 2018;246(4):257-64.

https://doi.org/10.1620/tjem.246.257

PMid:30568073

Rabbie SC, Martin PD, Flanagan T, Basit AW, Standing JF. Estimating the variability in fraction absorbed as a paradigm for informing formulation development in early clinical drug development. Eur J Pharm Sci. 2016 Jun;89:50-60.

https://doi.org/10.1016/j.ejps.2016.04.005

PMid:27072431

Vinarov Z, Abdallah M, Agundez JAG, Allegaert K, Basit AW, Braeckmans M, et al. Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review. Eur J Pharm Sci. 2021 Jul;162:105812.

https://doi.org/10.1016/j.ejps.2021.105812

PMid:33753215

Chrcanovic BR, Albrektsson T, Wennerberg A. Dental implants in irradiated versus non-irradiated patients: A meta-analysis. Clin Implant Dent Relat Res. 2014;16(5):784-92.

Sakakura CE, Margonar R, Sartori R, Morais JAND, Marcantonio E. The Influence of Cyclosporin A on Mechanical Retention of Dental Implants Previously Integrated to the Bone: A Study in Rabbits. J Periodontol. 2006 Dec;77(12):2059-62.

https://doi.org/10.1902/jop.2006.050290

PMid:17209791

Radzewski R, Osmola K. The Use of Dental Implants in Organ Transplant Patients Undergoing Immunosuppressive Therapy: An Overview of Publications. Implant Dent. 2016 Aug;25(4):541-6.

https://doi.org/10.1097/ID.0000000000000417

PMid:27002776

Chappuis V, Avila‐Ortiz G, Araújo MG, Monje A. Medication‐related dental implant failure: Systematic review and meta‐analysis. Clin Oral Implants Res. 2018 Oct;29(S16):55-68.

https://doi.org/10.1111/clr.13137

PMid:30328197

Mendes V, Dos Santos GO, Calasans-Maia MD, Granjeiro JM, Moraschini V. Impact of bisphosphonate therapy on dental implant outcomes: An overview of systematic review evidence. Int J Oral Maxillofac Surg. 2019 Mar;48(3):373-81.

https://doi.org/10.1016/j.ijom.2018.09.006

PMid:30314708

Bonacina R, Mariani U, Villa F, Villa A. Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients. J Can Dent Assoc. 2011;77(77):b147.

Appoo A, Christensen BL, Somayaji R. Examining the association of immunosuppressants and wound healing: A narrative review. World Counc Enteros Ther J. 2024 Sep;44(3):12-9.

https://doi.org/10.33235/wcet.44.3.12-19/

Khojasteh A, Dehghan MM, Nazeman P. Immediate implant placement following 1-year treatment with oral versus intravenous bisphosphonates: a histomorphometric canine study on peri-implant bone. Clin Oral Investig. 2019 Apr;23(4):1803-9.

https://doi.org/10.1007/s00784-018-2579-7

PMid:30187256

Kim HW, Lee MW, Lee JH, Kim MY. Comparison of the Effect of Oral Versus Intravenous Bisphosphonate Administration on Osteoclastogenesis in Advanced-Stage Medication-Related Osteonecrosis of the Jaw Patients. J Clin Med. 2021 Jul 4;10(13):2988.

https://doi.org/10.3390/jcm10132988

PMid:34279472 PMCid:PMC8268194

Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg. 2022 May 1;80(5):920-43.

https://doi.org/10.1016/j.joms.2022.02.008

PMid:35300956

Altalhi AM, Alsubaihi AA, Aldosary MM, Alotaibi LF, Aldosariy NM, Alwegaisi AK, et al. Enhancing the Oral Rehabilitation and Quality of Life of Bisphosphonate-Treated Patients: The Role of Dental Implants. Cureus [Internet]. 2023 Oct 7 [cited 2024 Oct 16];15(10):46654.

https://doi.org/10.7759/cureus.46654

Marx RE. Reconstruction of Defects Caused by Bisphosphonate-Induced Osteonecrosis of the Jaws. J Oral Maxillofac Surg. 2009 May;67(5):107-19.

https://doi.org/10.1016/j.joms.2008.12.007

PMid:19371821

Salgueiro M, Stribos M, Zhang LF, Stevens M, Awad ME, Elsalanty M. Value of pre-operative CTX serum levels in the prediction of medication-related osteonecrosis of the jaw (MRONJ): a retrospective clinical study. EPMA J. 2019 Mar 1;10(1):21-9.

https://doi.org/10.1007/s13167-019-0160-3

PMid:30984311 PMCid:PMC6459452

Brock G, Barker K, Butterworth CJ, Rogers S. Practical considerations for treatment of patients taking bisphosphonate medications: an update. Dent Update. 2011 Jun 2;38(5):313-26.

https://doi.org/10.12968/denu.2011.38.5.313

PMid:21834312

Khan AA, Sándor GKB, Dore E, Morrison AD, Alsahli M, Amin F, et al. Canadian Consensus Practice Guidelines for Bisphosphonate Associated Osteonecrosis of the Jaw. J Rheumatol. 2008 Jul 1;35(7):1391-7.

Goiato MC, Dos Santos DM, Rondon BCS, Moreno A, Baptista GT, Verri FR, et al. Care Required When Using Bisphosphonates in Dental Surgical Practice. J Craniofac Surg. 2010 Nov;21(6):1966-70.

https://doi.org/10.1097/SCS.0b013e3181f5031c

PMid:21119471

Kalra S, Jain V. Dental complications and management of patients on bisphosphonate therapy: A review article. J Oral Biol Craniofacial Res. 2013 Jan;3(1):25-30.

https://doi.org/10.1016/j.jobcr.2012.11.001

PMid:25737876 PMCid:PMC3942225

Abtahi J, Agholme F, Aspenberg P, Tengvall P. A bisphosphonate-coating improves the fixation of metal implants in human bone. Acta Biomater. 2012;8(10):3838-45.

https://doi.org/10.1016/j.bone.2012.02.151

Momand P, Becktor JP, Naimi-Akbar A, Tobin G, Götrick B. Effect of antibiotic prophylaxis in dental implant surgery: A multicenter placebo-controlled double-blinded randomized clinical trial. Clin Implant Dent Relat Res. 2022 Feb;24(1):116-24.

https://doi.org/10.1111/cid.13068

PMid:35075765 PMCid:PMC9306815

Bermúdez-Bejarano EB, Serrera-Figallo MÁ, Gutiérrez-Corrales A, Romero-Ruiz MM, Castillo-de-Oyagüe R, Gutiérrez-Pérez JL, et al. Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates. J Clin Exp Dent. 2017 Jan 1;9(1):e141.

Spanou A, Nelson K, Ermer MA, Steybe D, Poxleitner P, Voss PJ. Primary wound closure and perioperative antibiotic therapy for prevention of bisphosphonate-related osteonecrosis of the jaw after tooth extraction. Quintessence Int Berl Ger 1985. 2020;51(3):220-8.

Kim A (Seongju), Abdelhay N, Levin L, Walters JD, Gibson MP. Antibiotic prophylaxis for implant placement: a systematic review of effects on reduction of implant failure. Br Dent J. 2020 Jun;228(12):943-51.

https://doi.org/10.1038/s41415-020-1649-9

PMid:32591710 PMCid:PMC7319948

Matias De Assis G, Queiroz S, Germano A. Systemic Use of Antibiotics in Dental Implant Surgeries in Immunocompetent Patients: A Blind Randomized Controlled Trial. Int J Oral Maxillofac Implants. 2023 Dec 12;38(6):1168-74.

https://doi.org/10.11607/jomi.10115

PMid:38085748

Wang AS, Armstrong EJ, Armstrong AW. Corticosteroids and wound healing: clinical considerations in the perioperative period. Am J Surg. 2013 Sep;206(3):410-7.

https://doi.org/10.1016/j.amjsurg.2012.11.018

PMid:23759697

Hernández G, Paredes V, López-Pintor R. Implant treatment in immunosuppressed renal transplant patients: A prospective case-controlled study. Clin Oral Implants Res. 2019;30(6):524-30.

https://doi.org/10.1111/clr.13437

PMid:30980770

Lazarovici TS, Yahalom R, Taicher S, Schwartz-Arad D, Peleg O, Yarom N. Bisphosphonate-Related Osteonecrosis of the Jaw Associated With Dental Implants. J Oral Maxillofac Surg. 2010 Apr;68(4):790-6.

https://doi.org/10.1016/j.joms.2009.09.017

PMid:20307764

Tenore G, Zimbalatti A, Rocchetti F, Graniero F, Gaglioti D, Mohsen A, et al. Management of Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Leukocyte- and Platelet-Rich Fibrin (L-PRF) and Photobiomodulation: A Retrospective Study. J Clin Med. 2020 Oct 29;9(11):3505.

https://doi.org/10.3390/jcm9113505

PMid:33138266 PMCid:PMC7693575

Romanos GE, Vaglica M, Sculean A. Drug-associated bone resorption with potential dental and implant implications. Periodontol 2000. 2022;90(1):236-46.

https://doi.org/10.1111/prd.12461

PMid:35916776

Downloads

Published

2024-12-31

How to Cite

Eisa Aldabeab, K., & Alsuwaiyan, A. (2024). The Impact of Systemic Drug Therapies (Bisphosphonates and Immunosuppressants) on Dental Implant Success: A clinical review : The Impact of Systemic Drug Therapies on Dental Implant Success. Galen Medical Journal, 13(SP1), e3666. https://doi.org/10.31661/gmj.v13iSP1.3666